Unique ID issued by UMIN | UMIN000014034 |
---|---|
Receipt number | R000016343 |
Scientific Title | Synergy Effect of the ARB plus HCTZ Combination therapy on Na dynamics in CKD |
Date of disclosure of the study information | 2014/05/22 |
Last modified on | 2015/09/22 09:19:22 |
Synergy Effect of the ARB plus HCTZ Combination therapy on Na dynamics in CKD
Synergy Effect of ARB/HCTZ Combination on Na dynamics
Synergy Effect of the ARB plus HCTZ Combination therapy on Na dynamics in CKD
Synergy Effect of ARB/HCTZ Combination on Na dynamics
Japan |
Chronic kidney disease(CKD)
Nephrology |
Others
NO
To investigate the condition in which the synergy effect of ARB/HCTZ combination therapy on the natriuresis can be promised.
Efficacy
Exploratory
Pragmatic
Phase II
Changes in the tubular sodium load (PNa x GFR), tubular sodium reabsorption, and urinary sodium excretion, circadian rhythms of blood pressure and natriuresis
Urinary angiotensinogen excretion (intrarenal RAS activity), ultrasonic examination of the kidney (RI), heart rate variability obtained by holter ECG (sympathetic activity)
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Uncontrolled
2
Treatment
Medicine |
additional medication of losartan (50mg/d) for 2 months to the preceding 2 month-treatment with HCTZ (12.5mg/d)
additional medication of HCTZ (12.5mg/d) for 2 months to the preceding 2 month-treatment with losartan (50mg/d)
20 | years-old | <= |
Not applicable |
Male and Female
1. age 20y or more
2. CKD based on K/DOQI criteria
3. Office BP >130/80 on at least one occasion before enrollment
4. documented informed consent
1. previous treatment with ARB or diuretics 2 months before enrollment
2. contraindication to losartan or HCTZ (history of the allergic reaction, bilateral renal artery stenosis)
3. presence or possibility of pregnancy
4. HbA1c >9.0 %
5. GOT >100, or GPT >85
6. endocrine hypertension
7. accelerated or malignant hypertension
8. serious conditions with congestive heart failure, coronary diseases, arrhythmia or systemic diseases
9. nephrotic syndrome (serum albumin <2.5 g/dl)
10. patients under hemodialysis therapy
11. any reason for ineligibility suggested by the attending doctor
40
1st name | |
Middle name | |
Last name | Michio Fukuda |
Nagoya City University Graduate School of Medical Sciences
Cardio-Renal Medicine and Hypertension
1 Kawasumi, Mizuho-ku, Nagoya 467-8601, Japan
81-52-853-8221
m-fukuda@med.nagoya-cu.ac.jp
1st name | |
Middle name | |
Last name | Toshiyuki Miura |
Nagoya City University Graduate School of Medical Sciences
Cardio-Renal Medicine and Hypertension
1 Kawasumi, Mizuho-ku, Nagoya 467-8601, Japan
81-52-853-8221
tmiura@med.nagoya-cu.ac.jp
Department of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences
None
Self funding
Japan
NO
名古屋市立大学病院 Nagoya City University Hospital
2014 | Year | 05 | Month | 22 | Day |
http://www.med.nagoya-cu.ac.jp/cr.dir/
Unpublished
start-up meeting held.
none enrolled
Enrolling by invitation
2014 | Year | 02 | Month | 07 | Day |
2014 | Year | 02 | Month | 07 | Day |
2016 | Year | 01 | Month | 01 | Day |
2017 | Year | 01 | Month | 01 | Day |
2017 | Year | 01 | Month | 01 | Day |
2017 | Year | 01 | Month | 01 | Day |
2014 | Year | 05 | Month | 22 | Day |
2015 | Year | 09 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016343
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |